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Enhanced insulin sensitivity in extrarenal potassium handling in uremic
rats. Translocation of potassium to the intracellular compartment is
impaired in advanced chronic renal failure. The purpose of this study
was to evaluate the role of endogenous insulin in the disposal of an oral
potassium load in uremia. Experiments were done on male Sprague-
Dawley rats. Chronic renal failure (CRF) was induced by 3/4 nephrec-
tomy. The results show that the addition of oral glucose to a potassium
load was more effective in the translocation of potassium to the
intracellular compartment in uremic animals. Further, suppression of
endogenous insulin secretion with somatostatin caused a much higher
increase in plasma potassium (K) of uremic rats (1.09 0.15 mEq/liter
in CRF vs. 0.28 0.03 mEq/liter in control). Experiments to assess the
activity of the Na pump were done in soleus muscles derived from these
animals. Although a 50% reduction of the basal Na pump activity was
found in the uremic muscles, the addition of insulin 100 mU/ml caused
a relatively greater stimulation of ouabain-sensitive 86Rb uptake in the
uremic muscle as compared to the control tissue (203% vs. 77%
increment). These data suggest a greater sensitivity to insulin action on
extrarenal potassium disposal in uremia.
It is known that in chronic renal failure, as renal mass is
diminished, there is a remarkable adaptive increase in potas-
sium excretion by the remaining functioning nephrons. It has
also been reported that in uremia, there is increased gastroin-
testinal potassium secretion resulting in an elevated stool po-
tassium content [1]. These mechanisms, known as potassium
adaptation, explain the fact that humans and animals with renal
insufficiency do not develop serious hyperkalemia until glomer-
ular filtration rate is severely reduced [2]. The increase in
potassium excretion in uremia has been explained by the
increment in the number of sodium pumps of the secretory
epithelia [3]. On the contrary, a defect in extrarenal potassium
disposal in azotemia has been postulated by us [41 and others
[5], even though some reports indicate normal or enhanced
extrarenal potassium disposal in chronic renal failure [6, 7].
Little is known about the effect in uremia of the different
hormones that participate in the extrarenal potassium homeo-
stasis. It is well known that insulin plays a key role in potassium
handling during normal conditions [8] as well as after potassium
administration [9], and it has been reported that insulin-depen-
dent potassium uptake is normal in chronically uremic human
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subjects [10]. But the role of endogenous insulin in the extra-
renal potassium tolerance has not been assessed.
In the present study we have studied the role of endogenous
insulin in non-renal potassium disposal in chronic uremic rats.
We examined the response to an acute load of potassium, alone
or after a combined oral load of carbohydrates and potassium
by measuring removal of this cation from the extracellular
compartment. In addition, the effect of somatostatin infusion on
the basal plasma potassium concentration was compared be-
tween uremic and control rats. Finally, we examined the effect
in vitro of insulin on active cation transport in skeletal muscle
tissue from azotemia and control animals. The results indicate
that in uremic rats there is an enhanced response to the
hypokalemic action of insulin, as well as an increased sensitiv-
ity to ouabain.
Methods
Animals
Male Sprague-Dawley rats weighing 250 to 300 g were used in
all studies. Chronic renal failure was induced by ligating
branches of the left renal artery to infarct about 3/4 of the
kidney; a right nephrectomy was also performed during the
surgical procedure. Subsequently, control and experimental
rats were pair fed. Pair feeding was accomplished by giving
control rats the same amount of diet as eaten by nephrecto-
mized rats the day before.
The experiments were done three to four weeks after surgery.
Plasma creatinine, blood arterial gases and plasma potassium
were measured at the beginning of the each study to asses the
degree of azotemia.
Potassium load
An oral potassium load of 3.5 mEq per kilogram of body
weight was administered to control and uremic animals after an
overnight fast. The oral load was given through an orogastric
tube. A jugular catheter was inserted the day before the study.
Two blood samples were drawn before the oral load to obtain
basal values of plasma potassium. Blood samples were drawn
30, 60, 90 and 120 minutes after the administration of the
potassium load.
To evaluate the urinary excretion of this cation after the
potassium load, rats were placed in metabolic cages and urine
collected for two hours before the potassium administration and
during the two hours of the study. The urinary potassium
excretion due to the oral load was calculated as mEq of
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potassium excreted during the experimental period minus the
mEq of potassium excreted during two hours before the study.
Oral mixed potassium and carbohydrate load
One or two days after the potassium oral load, the same rats
received a mixed potassium and carbohydrate load. The proto-
col was the same used in the potassium load with the exception
that glucose 2 g per kilogram of body weight was administered
simultaneously with potassium.
Somatostatin infusion
Control and uremic rats were anesthetized with Nembutal (45
and 35 mg/kg body wt, respectively, i.p.). A tracheostomy was
performed and right carotid and left jugular were cannulated. A
saline infusion (NaCl 0.9%) was started through the jugular
catheter. After a stabilization period of 45 minutes the infusion
of somatostatin (6 g/K/min) was started. Blood was drawn at
0, 30, 60, 90 minutes to determine potassium levels. Basal and
90 minute insulin levels were measured by radioinmunoanalysis
with a specific antibody.
86Rb transport in skeletal muscle
The experiments were done in soleus muscle obtained from
control and uremic animals. The muscle was removed by the
method described by Kjeldsen, Norgaard and Clausen [11].
After the muscle was isolated, group of fibers weighing 8 to 15
mg were incubated in separate vials.
The muscular fibers were washed for 15 minutes in 2 ml of
Krebs-Ringer Buffer (KRB) containing (millimolar) 4.2 KC1;
1.19 KH2PO4; 120 NaC1; 25 NaHCO3; 1.2 MgSO4; 1.3 CaCI2; 5
D-glucose; (pH: 7.40). The buffer was continuously gassed with
95% 02 and 5% CO2. Thereafter, the muscles were preincu-
bated for 30 minutes in KRB in the presence or absence of 1 mM
ouabain. Finally, the muscles were incubated for 20 minutes in
2 ml of KRB containing 86Rb (0.1 jCi/ml) in the presence or
absence of 100 mU insulin and/or 1 ma'i ouabain. The reaction
was stopped by transferring the muscle into iced KRB; the
muscles were washed in cold buffer and blotted. Radioactivity
of the samples was determined by the Cerenkov radiation in a
liquid scintillation counter.
Statistics
The results are expressed as means SEM. Statistical com-
parisons were done by the Student's i-test or by analysis of
variance when appropriate.
Results
The characteristics of experimental animals, three weeks
after partial nephrectomy, were compared to control rats (Table
1). The nephrectomized rats had established renal insufficiency,
as shown by the increment in plasma creatinine values. The
experimental animals have similar weights and blood pH. To
assess the acute extrarenal tolerance to potassium in the uremic
rats, an oral potassium load of this cation was administered.
The administration of the potassium load induced a higher
increment in plasma potassium concentration in the uremic
animals as compared to control rats (Fig. 1). The maximal
increment in plasma potassium (Kmax) was 3.6 0.25 mEq/
liter in the uremic rats and of 1.7 0.045 mEq/liter in the
control animals. When the urinary losses of K were taken into
Table 1. Characteristics of uremic and control rats
Controls CRF
(N= 12) (N= 12)
Body weight g 306.2 5.5 310.7 6.4
Plasma creatinine mg/dl 0.6 0.08 2.0 0.15a
Potassium mEqiliter 3.90 0.13 3.88 0.13
Blood pH 7.40 0.01 7.44 0.01
Bicarbonate mEqiliter 25.4 1.2 22.3 0.18
Values of controls and uremic rats (CRF) are given as mean SE.
a P < 0.05
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Fig. 1. Time related changes in plasma potassium concentration in
uremic and control rats after an oral load of potassium alone (3.5 mEq
K/kg body WI) or a mixed load of potassium plus glucose (2 g/kg body
wt), Symbols are: (0) control with K alone (N = 6); (•) controls with
mixed load (N = 5); (Lx) uremic with K alone (N = 4); (A) uremic with
mixed load (N = 4). Values are mean SE. Analysis of variance
indicates significant differences between the four curves (P < 0.05).
Urinary potassium excretion prior to potassium load was: 28.4 2.5
and 22.6 3.5 Eq K/l20 minIlOO g body wt for controls and uremic
rats, respectively. After oral potassium load, urinary potassium values
were: controls with K alone, 39.3 2.0; uremic with K alone, 28.1
5.0; controls K plus glucose, 38.3 2.8; uremic K plus glucose, 24.0
3.2 sEq K/l20 min/lOO g body wt.
account (LKmax/K retained) the corrected Kmax was still
significantly higher in uremic animals than in controls: 3.34
0.5 in uremic rats and 1.59 0.2 in the control rats (P < 0.05).
To evaluate the role of endogenous insulin secretion on
potassium handling, a mixed oral load of potassium and glucose
was administered. The addition of glucose caused a significant
increase in the translocation of potassium out of the extracel-
lular compartment, both in experimental and control animals
(Fig. 1). Further, at 60 minutes after the mixed load the uremic
and control rats had similar zIK values. The potassium removed
from the extracellular space after the addition of glucose was
calculated assuming an extracellular volume of 20% of body
weight for both groups; the results are summarized in Table 2.
Glucose-induced potassium removal was significantly higher in
the uremic rats, and at 60 minutes both groups of animals
achieved similar total potassium translocation, suggesting a
major role for endogenous insulin in potassium homeostasis in
the uremia.
The effect of insulin in maintaining the fasting potassium
levels was assessed by a somatostatin infusion. The rise in
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Table 2. Effect of glucose on the amount of the potassium removed
from the extracellular compartment at 30 and 60 minutes after an oral
load
K removed pEq/1OO g body wt
CRFControls
30 minutes after oral load
Potassium 314.7 1.1 289.5 5.oa
K + glucose 339.5 2.7C 322.6 2.5IC
Glucose-mediated 24.8 33.1
60 minutes after oral load
Potassium 321.3 0.2 308.4 l.7
K + glucose 344.3 0.7C 3433
Glucose-mediated 23.0 34.9
Values represent mean sa of the amount of potassium translocated
out of the extracellular compartment after an oral load of K alone (3.5
mEq/kg body wt) or a mixed load (3.5 mEq K and 2 g glucose/kg body
wt), assuming an extracellular volume of 20% body wt for each group.
Urinary K excretion was subtracted (legend Fig. 1). Glucose mediated
translocation represents the difference in the removal of K (SEq K/100
g body wt) with and without glucose.
a Significantly different from control, P < 0.01
b Significantly different from control, P < 0.05
Significant difference for each group with glucose, P < 0.01
d Not significantly different from control group at 60 mm
Fig. 2. Time related increase in plasma potassium concentration in
uremic (•), and control (0) rats, under the infusion of somatostatifl: 6
pg/kg/body wi/mm (N = 3foreach group). *Significant differences, 0
0.0001.
*
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Fig. 3. Uptake of 86Rb in rat soleus muscle fibers of uremic () and
control (LI) rats. Values represent mean SE of 6 experiments done in
triplicate samples. Total uptake represents the maximal uptake at 20
minutes and ouabain-sensitive 86Rb uptake was measured with 1O M
ouabain (N = 6 for both groups). *P < 0.002 and ** <0.0001 by paired
analysis.
Table 3. Effect of insulin in the Na,K-ATPase activity of the soleous
Total Ouabajri
uptake sensitive
E
+
E(a
1.2
1.0
0.8
0.6
0.4
0.2
0 30 60 90
Time, minutes
muscle
Ouabain-sensitive 86Rb uptake
nmol/g wet wi/mm
Controls CRF
(N=4) (N=3)
Basal
Plus insulin
Insulin mediated
191.3 9.7 87.3 21.4a
338.3 l9C 264.7 275b
76.9% 203.2%
fasting potassium levels due to somatostatin infusion was
several times higher in uremic animals as compared to controls:
1.09 0.1 versus 0.28 0.03 mEq/liter, respectively (Fig. 2).
Basal insulin levels were similar in both groups 41.1 5.8
mU/mi in control and 38.2 7.2 in uremia, at the end of
somatostatin infusion plasma insulin dropped to 5.3 2.0 and
7.6 2.5, respectively.
Further studies to elucidate the nature of the insulin-depen-
dent effect on K translocation were accomplished in isolated
skeletal muscle. The 86Rb uptake by the soleus muscle was
studied because the skeletal muscle is an insulin sensitive
tissue, and it is the biggest reservoir of potassium in the body.
Initial experiments were directed to determine the muscle Na,
K-ATPase activity in control and uremic rats by measuring
ouabain-sensitive radioisotope fluxes. Figure 3 includes the
results on 86Rb uptake of the isolated soleus fibers. As shown in
The activity of the sodium pump was measured in the presences of
10-2 M ouabain. 86Rb uptake was measured at 20 mm in parallel samples
with and without insulin (100 mU/mi) in the incubation media, as
indicated in Methods.
a P < 0.05 control vs. uremia
b p < 0.01 and P < 0.05 basal vs. insulin
the Figure, there is an impaired ouabain-sensitive uptake in the
uremic rat muscle. In fact, over a 50% of reduction on the pump
activity was observed, even though the non-ouabain dependent
uptake was similar for both groups.
The same type of measurements were repeated in another
series of experiments done in the presence of insulin. As shown
(Table 3), insulin caused a significant stimulus on the Na,
K-ATPase activity in both groups. However, the insulin medi-
ated enhancement on the Na pump activity was comparatively
higher in the uremic soleus as compared to controls. As shown
in the table, insulin enhanced the ouabain sensitive 86Rb uptake
three times in the uremic tissue and 1.8 times in controls.
Hormone dependent increment in the uremic soleus was 203%
versus 76.9% in normal tissue.
The results obtained in vivo, as with the results in vitro,
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Fig. 4. Ouabain inhibition of 86Rb uptake in rat soleus muscle fibers.
Soleus muscles from control () and uremic rats () were incubated at
37°C for 30 minutes in KRB buffer containing various concentrations of
ouabain. The fibers were then transferred to new fiaskes containing the
same amount of ouabain, and 86Rb uptake was initiated by the addition
of the isotope. Total Na,K-ATPase activity was measured as 102 M
ouabain sensitive 86Rb uptake (N = 5 for each group).
suggest a higher sensitivity to insulin in the uremic animals.
Recently it has been shown that only the alpha 2 isoform of the
Na, K-ATPase is insulin-dependent [12, 13] and that this
isoform has a greater affinity for ouabain. Therefore, the effect
of different concentrations of ouabain on the 86Rb uptake was
studied in the soleus muscle of control and azotemic animals.
Figure 4 indicates that a greater inhibition of the pump activity
was observed in the uremic tissue with low doses of ouabain as
compared to control animals. As shown in the Figure, in the
presence of l0 M of ouabain the remaining activity of the Na,
K-ATPase was 54.7 11.1% in the uremic muscle in contrast to
the normal animals that had 93 1.95% of the total activity of
the pump. At higher concentration, 10 M ouabain, the Na,
K-ATPase activity in the control animals was 51.8 1.8% and
only 11.2 2.6% in the uremic muscle.
Discussion
The ability to avoid hyperkalemia following an acute potas-
sium load is at least partially dependent on tissue buffering.
During the first three to six hours following an acute potassium
load only about half of the administered load appears in the
urine. The bulk of the retained potassium is removed into the
intracellular space. The Na, K-ATPase is the enzyme respon-
sible for actively pumping sodium out of, and potassium into,
almost every eukaryote cell. The importance of the pump in
maintaining many vital functions suggests that the study of the
defect of the Na, K-pump in disease states, such as chronic
renal failure, would yield important insights into their patho-
physiology. Most work on the sodium pump of symmetrical
cells in uremia has been related to studies in erythrocyte where
wider inter-individual variations in cell Na, on genetic basis or
cell age, could explain the discrepancies observed by different
authors [3, 14].
A number of hormones have been shown to participate in
potassium homeostasis by modulating the activity of the Na,
K-ATPase. Few studies have been directed to determine hor-
monal control on extrarenal potassium homeostasis in uremia.
Abnormalities in the concentrations of these hormones or in
their action on target tissues have been described in CRF. Thus,
despite the presence of a high immunoreactive level of insulin,
CRF is associated with end-organ resistance to the glucose
translocation effect of insulin [15, 16]. Nevertheless, some
groups [10, 17] have suggested that insulin-dependent potas-
sium uptake by extrarenal tissues was normal in CRF.
Our results in an experimental model of chronic uremia
clearly indicate that in the rat there is an impaired extrarenal
handling of potassium. This defect is at least partially explained
by a diminished ouabain-sensitive potassium uptake by the
skeletal muscle of the uremic rat, as measured by 86Rb a
radioisotope potassium analogue. Similar results have been
recently reported by Druml et al [18] in epithrochlearis muscle
from rats with chronic renal failure.
The presence of a defect in muscular Na, K-ATPase activity
in uremia was further supported by our in vivo studies on the
distribution of an oral load of potassium; we found that at 30 or
60 minutes after potassium administration the magnitude of the
plasma cation increment was significantly higher in uremic rats
(Fig. 1), suggesting a diminished shift of potassium from its
extracellular to intracellular compartments. As it has been well
established, the urinary or fecal losses of potassium are minimal
during the first hour after an oral load of this cation [9]. Our
measurements of urinary potassium losses confirm above data,
in fact less than 5% of the potassium load was excreted in the
urina during the 120 minutes of the study period. Excretion of
potassium into the colon might have some role in extrarenal
potassium disposal. However, it is unlikely that fecal excretion
of potassium in the rat plays an important role in potassium
homeostasis [19]. Further, we have assumed an extracellular
space of 20% for both groups and it is presumable that uremic
rats have a higher extracellular compartment than controls;
therefore our assumption ameliorates potassium handling in the
uremic rats.
Because insulin is known to play an important role in
extrarenal potassium homeostasis during normal conditions [8,
20], we have examined the ability of physiological hyperinsulin-
ism to stimulate potassium uptake by extrarenal tissues in
uremic rats. The magnitude of the increment in plasma potas-
sium concentration observed when the mixed oral load of
carbohydrates and potassium was administered agreed well
with the expected hypokalemic effect of insulin. Plasma potas-
sium levels returned in both groups to initial values within the
60 minutes after the mixed load of potassium. The interesting
feature of these experiments was the fact that glucose-mediated
potassium translocation was comparatively higher in uremic
animals as compared to controls. These results point to an
important role for insulin in the potassium handling in uremia,
in contrast to the impaired glucose uptake by peripheral tissues
[15]. The present results with somatostatin infusion in uremic
animals further confirms the importance of insulin in potassium
homeostasis in chronic renal failure.
In fact, in control rats, inhibition of fasting insulin secretion
with somatostatin resulted in hyperkalemia (K 0.28 0.03
mEq/liter) similar to that described in human and other species
[21]. When somatostatin was infused in uremic rats, a much
larger rise in plasma potassium (1.09 0.1 mEq/liter) was
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observed. Alvestrand et al suggested that potassium uptake by
extrarenal tissues, induced by insulin, was greater in azotemic
subjects than in controls, and even though in his study the
differences were not significant [101, our results confirm their
supposition. Further the results of our in vitro experiments
indicate that insulin stimulates the uptake of 86Rb mediated by
the Na, K-ATPase in the soleus muscle tissue of normal and
uremic rats. Insulin activation of monovalent cation transport
has been reported in several other systems including soleus
muscle from normal rats [22]. The present results indicate that
the sensitivity of the uremic tissue to insulin was enhanced as
compared to soleus from control rats. In fact, exposure of
uremic muscle to 100 mU/mi of insulin results in 200% increase
on ouabain-sensitive 86Rb influx, whereas a 77% of increment
was observed in control tissue. (Not every batch of insulin was
effective in activating the sodium pump in control rat tissue;
only those batches that had a significant effect on normal
animals were tested in uremia; the in vitro unresponsiveness to
insulin has also been described by others [18]).
The existence in muscle cells of at least two molecular forms
of the catalytic alpha subunit of the Na,K-ATPase (sl and a2)
has been demonstrated. Only the a2 isoform of the enzyme was
activated by insulin stimulation in muscle and adipose cells [12].
This isoform has a higher affinity for ouabain [13]. Our results
suggest that changes in the ouabain sensitivity of the pump
takes place in this uremic tissue. This heterogenous response to
insulin and ouabain in the uremia is observed concomitantly
with a diminished total Na,K-ATPase activity, suggesting a
possible inhibition of the al isoform of the pump in the uremic
tissues. Future studies should be directed to determine the
mechanisms involved in the modifications of the Na-pump
activity observed in the present work. In fact, it is possible that
in uremia the expression of the Na,K-ATPase is modulated by
some intrinsic factor(s) unknown at the present time, which
would affect the tissue specific expression of various isoforms
of the Na,K-ATPase.
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